Deutsche Bank’s MedAvail Holdings, Inc. Common Stock MDVL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-1,600
Closed -$77K 4386
2022
Q1
$77K Sell
1,600
-272
-15% -$16.3K ﹤0.01% 3682
2021
Q4
$131K Buy
1,872
+8
+0.4% +$862 ﹤0.01% 3583
2021
Q3
$272K Buy
1,864
+1,725
+1,241% +$523K ﹤0.01% 3409
2021
Q2
$85K Buy
+139
New +$90.7K ﹤0.01% 4193
2019
Q3
Sell
-4
Closed -$3K 5366
2019
Q2
$3K Sell
4
-11
-73% -$9.03K ﹤0.01% 5159
2019
Q1
$13K Buy
+15
New +$14.3K ﹤0.01% 4872
2017
Q3
Sell
-1
Closed 5147
2017
Q2
$0 Hold
1
﹤0.01% 5177
2017
Q1
$1K Buy
+1
New +$1.84K ﹤0.01% 4839

Other funds holding MDVL

Deutsche Bank's MDVL Position: Q2 2022 in Review

Deutsche Bank sold out of MedAvail Holdings, Inc. Common Stock (MDVL) in Q2 2022, closing a stake of 1,600 shares — an estimated $77K sold.

Deutsche Bank first reported a position in MDVL in Q1 2017 and held it in 8 quarters. The position peaked at $272K in Q3 2021. 38 funds tracked by Wall St. Rank hold MDVL as of Q2 2022.

  • Deutsche Bank reported no remaining MedAvail Holdings, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Deutsche Bank sold 1,600 MedAvail Holdings, Inc. Common Stock shares in Q2 2022, an estimated $77K.
  • Deutsche Bank first reported a position in MedAvail Holdings, Inc. Common Stock in Q1 2017 and held it in 8 quarters.
  • Deutsche Bank's MedAvail Holdings, Inc. Common Stock position peaked at $272K in Q3 2021.
  • 38 funds tracked by Wall St. Rank held MedAvail Holdings, Inc. Common Stock as of Q2 2022.

Based on Deutsche Bank's 13F filing for Q2 2022, filed 11 Aug 2022.